BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21200380)

  • 1. Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases.
    Lin H; Xu R; Zhang Z; Chen L; Shi M; Wang FS
    Cell Mol Immunol; 2011 Jan; 8(1):19-22. PubMed ID: 21200380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of mesenchymal stem cells in liver injury.
    Puglisi MA; Tesori V; Lattanzi W; Piscaglia AC; Gasbarrini GB; D'Ugo DM; Gasbarrini A
    J Biomed Biotechnol; 2011; 2011():860578. PubMed ID: 22228987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.
    Hu C; Wu Z; Li L
    J Cell Mol Med; 2020 Jan; 24(1):40-49. PubMed ID: 31691463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases.
    Liu P; Yao L; Hu X; Wang Z; Xiong Z; Jiang Y
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1099-1106. PubMed ID: 37271943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.
    Lee DK; Song SU
    Cell Immunol; 2018 Apr; 326():68-76. PubMed ID: 28919171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mesenchymal stem cells in liver injury.
    Sun H; Shi C; Ye Z; Yao B; Li C; Wang X; Qian Q
    Cell Biol Int; 2022 Apr; 46(4):501-511. PubMed ID: 34882906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Stem Cell Treatment on Acute Liver Failure Model Using Scaffold.
    Kang HT; Jun DW; Jang K; Hoh JK; Lee JS; Saeed WK; Chae YJ; Lee JH
    Dig Dis Sci; 2019 Mar; 64(3):781-791. PubMed ID: 30421375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells attenuate sepsis-induced liver injury via inhibiting M1 polarization of Kupffer cells.
    Liang X; Li T; Zhou Q; Pi S; Li Y; Chen X; Weng Z; Li H; Zhao Y; Wang H; Chen Y
    Mol Cell Biochem; 2019 Feb; 452(1-2):187-197. PubMed ID: 30178273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
    Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
    PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges.
    Yadav P; Singh SK; Rajput S; Allawadhi P; Khurana A; Weiskirchen R; Navik U
    Pharmacol Ther; 2024 Jan; 253():108563. PubMed ID: 38013053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
    Nagaishi K; Ataka K; Echizen E; Arimura Y; Fujimiya M
    Hepatology; 2014 May; 59(5):1816-29. PubMed ID: 24375439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases.
    Liu WH; Song FQ; Ren LN; Guo WQ; Wang T; Feng YX; Tang LJ; Li K
    J Cell Mol Med; 2015 Mar; 19(3):511-20. PubMed ID: 25534251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte differentiation of mesenchymal stem cells.
    Wu XB; Tao R
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):360-71. PubMed ID: 22893462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
    Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
    J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress.
    Kholodenko IV; Kholodenko RV; Yarygin KN
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages.
    Li YW; Zhang C; Sheng QJ; Bai H; Ding Y; Dou XG
    World J Gastroenterol; 2017 Dec; 23(45):7978-7988. PubMed ID: 29259373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles derived from human embryonic stem cell-MSCs ameliorate cirrhosis in thioacetamide-induced chronic liver injury.
    Mardpour S; Hassani SN; Mardpour S; Sayahpour F; Vosough M; Ai J; Aghdami N; Hamidieh AA; Baharvand H
    J Cell Physiol; 2018 Dec; 233(12):9330-9344. PubMed ID: 29266258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cell therapy for liver diseases.
    Alfaifi M; Eom YW; Newsome PN; Baik SK
    J Hepatol; 2018 Jun; 68(6):1272-1285. PubMed ID: 29425678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modification by overexpression of target gene in mesenchymal stromal cell for treating liver diseases.
    Hu C; Zhao L; Li L
    J Mol Med (Berl); 2021 Feb; 99(2):179-192. PubMed ID: 33388882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.